Arteris, Inc. (NASDAQ:AIP - Get Free Report) COO Laurent Moll sold 9,219 shares of the company's stock in a transaction that occurred on Monday, September 14th. The shares were sold at an average price of $20.85, for a total value of $192,216.15. Following the completion of the sale, the chief operating officer owned 212,478 shares of the company's stock, valued at $4,430,166.30. This trade represents a 4.16% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Arteris Trading Down 1.0%
Arteris stock traded down $0.20 during trading on Tuesday, reaching $20.41. 557,821 shares of the company were exchanged, compared to its average volume of 729,086. Arteris, Inc. has a 52-week low of $8.75 and a 52-week high of $50.26. The company has a market capitalization of $1.00 billion, a P/E ratio of -23.46 and a beta of 1.91. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.57 and a quick ratio of 1.57. The stock's 50 day simple moving average is $27.54 and its two-hundred day simple moving average is $27.81.
Arteris (NASDAQ:AIP - Get Free Report) last issued its earnings results on Thursday, August 6th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by ($0.06). Arteris had a negative net margin of 46.70% and a negative return on equity of 295.96%. The company had revenue of $24.13 million during the quarter, compared to analysts' expectations of $23.48 million. On average, equities research analysts expect that Arteris, Inc. will post -0.68 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently issued reports on AIP shares. Jefferies Financial Group raised shares of Arteris from a "hold" rating to a "buy" rating and upped their price objective for the company from $35.00 to $50.00 in a report on Friday, August 7th. Weiss Ratings raised shares of Arteris from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Friday, August 21st. Roth Capital started coverage on shares of Arteris in a research note on Tuesday, August 4th. They issued a "buy" rating and a $40.00 price target for the company. Oppenheimer assumed coverage on shares of Arteris in a report on Thursday, July 16th. They set an "outperform" rating and a $40.00 price target for the company. Finally, Rosenblatt Securities reaffirmed a "buy" rating and set a $38.00 price target on shares of Arteris in a research report on Friday, August 7th. Five research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, Arteris currently has a consensus rating of "Moderate Buy" and an average target price of $41.00.
Check Out Our Latest Stock Analysis on AIP
Institutional Trading of Arteris
A number of hedge funds and other institutional investors have recently modified their holdings of AIP. Needham Investment Management LLC raised its holdings in Arteris by 2.6% in the 4th quarter. Needham Investment Management LLC now owns 3,411,500 shares of the company's stock valued at $52,878,000 after buying an additional 86,500 shares during the period. BlackRock Inc. acquired a new stake in shares of Arteris during the second quarter valued at about $160,129,000. Granahan Investment Management LLC increased its position in shares of Arteris by 201.0% during the first quarter. Granahan Investment Management LLC now owns 713,077 shares of the company's stock valued at $11,723,000 after acquiring an additional 476,181 shares during the last quarter. Wellington Management Group LLP raised its stake in shares of Arteris by 0.4% in the 2nd quarter. Wellington Management Group LLP now owns 500,200 shares of the company's stock valued at $24,305,000 after acquiring an additional 1,897 shares during the period. Finally, Algert Global LLC acquired a new position in shares of Arteris in the 2nd quarter worth approximately $11,602,000. 64.36% of the stock is owned by institutional investors and hedge funds.
Arteris Company Profile
(
Get Free Report)
Arteris, Inc is a semiconductor intellectual property company that provides network-on-chip (NoC) interconnect and system IP for the design of complex systems-on-chip (SoCs). Its technologies help semiconductor and electronics companies connect processor cores, memory, peripherals and other functional blocks within a chip while supporting data movement, system integration and design reuse.
The company's product portfolio includes FlexNoC interconnect IP, Ncore cache-coherent interconnect IP and CodaCache system IP.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.